Ralimetinib
id:
ralimetinib-184-9108222
title:
Ralimetinib
text:
Ralimetinib (LY2228820) is a small molecule experimental cancer drug in development by Eli Lilly. Although originally thought to be a p38 mitogen-activated protein kinase (MAPK) inhibitor, it has since been reported that it acts instead as an epidermal growth factor receptor (EGFR) inhibitor. A phase II trial for treatment of ovarian cancer has completed.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Ralimetinib
date created:
2017-01-10T21:48:08Z
date modified:
2024-09-07T15:14:12Z
main entity:
{"identifier":"Q27088512","url":"https://www.wikidata.org/entity/Q27088512"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/7/71/Ralimetinib.png","width":926,"height":584}
fields total:
13
integrity:
16